[Federal Register Volume 64, Number 56 (Wednesday, March 24, 1999)]
[Notices]
[Pages 14292-14293]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-7156]
=======================================================================
-----------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Issuer Delisting; Notice of Application To Withdraw From Listing
and Registration; (Innovative Medical Services, Common Stock, and Class
A Common Stock Purchase Warrants) File No. 1-14468
March 18, 1999.
Innovative Medical Services (``Company'') has filed an application
with the Securities and Exchange Commission (``Commission''), pursuant
to Section 12(d) of the Securities Exchange Act of 1934 (``Act'') and
Rule 12d2-2(d) promulgated thereunder, to withdraw the above specified
securities (``Securities'') from listing and registration on the Boston
Stock Exchange, Inc. (``BSE'' or ``Exchange'').\1\
---------------------------------------------------------------------------
\1\ Notice of this application was previously issued by the
Commission as Release No. 34-41114 on February 25, 1999. Such
notice, however, failed to appear in the Federal Register, as
required, and so is being reissued.
---------------------------------------------------------------------------
The reasons cited in the application for withdrawing the Securities
from listing and registration include the following:
The Securities of the Company have been listed for trading on the
BSE and the Nasdaq SmallCap Market since August 8, 1996, pursuant to a
Registration Statement on Form 8-A which became effective on said date.
The Company has complied with the rules of the BSE by filing with
the Exchange a certified copy of the preambles and resolution adopted
by the Company's Board of Directors authorizing the withdrawal of its
Securities from listing on the BSE and by setting forth in detail to
the Exchange the reasons for the proposed withdrawal and the facts in
support thereof. In making the decision to withdraw its Securities from
listing on the BSE, the Company considered the direct and indirect
costs of maintaining dual listings of its Securities on the BSE and the
Nasdaq SmallCap Market. The
[[Page 14293]]
Company does not believe that due to the duplication of expenses of
continued listing on both Exchanges there is any benefit to continued
listing on the BSE.
The Exchange has informed the Company that it has no objection to
the withdrawal of the Company's Securities from listing on the BSE.
The Company's application relates solely to the withdrawal from
listing of the Securities from the BSE and shall have no effect upon
the continued listing of the Securities on the Nasdaq SmallCap Market.
Any interested person may, on or before, April 8, 1999, submit by
letter to the Secretary of the Securities and Exchange Commission, 450
Fifth street, N.W., Washington, D.C. 20549-0609, facts bearing upon
whether the application has been made in accordance with the rules of
the Exchange and what terms, if any, should be imposed by the
Commission for the protection of investors. The Commission, based on
the information submitted to it, will issue an order granting the
application after the date mentioned above, unless the Commission
determines to order a hearing on the matter.
For the Commission, by the Division of Market Regulation,
pursuant to delegated authority.
Margaret H. McFarland,
Deputy Secretary.
[FR Doc. 99-7156 Filed 3-23-99; 8:45 am]
BILLING CODE 8010-01-M
